Aperçu rapide pour TNF Receptor-Associated Factor 7 (TRAF7) (N-Term) Peptide (ABIN985443)
Antigène
TRAF7
(TNF Receptor-Associated Factor 7 (TRAF7))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Protein Region
N-Term
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-TRAF7 antibody (Catalog #: ARP43355_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
TRAF7
(TNF Receptor-Associated Factor 7 (TRAF7))
Sujet
Tumor necrosis factor (TNF, see MIM 191160) receptor-associated factors, such as TRAF7, are signal transducers for members of the TNF receptor superfamily (see MIM 191190). TRAFs are composed of an N-terminal cysteine/histidine-rich region containing zinc
Alias Symbols: DKFZp586I021, MGC7807, RFWD1, RNF119
Protein Interaction Partner: MAP3K3,TRAF7,CYLD,MAP3K3,TRAF6,TRAF7,MAP3K3